Awardee OrganizationSANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE
Description
Abstract Text
During spermatogenesis, germ cells make several important developmental
decisions. One of the most important is the choice to cease mitotic
proliferation and enter meiosis. Much has been learned about the switch
from mitosis to meiosis in lower organisms, but the study of the
molecules in the meiotic pathway and the factors which regulate them in
mammalian germ cells has been more difficult. The recent development of
mouse testicular cell lines, including two germ cell lines which undergo
meiosis in vitro, now make molecular studies of mammalian germ cell
differentiation more feasible. The experiments outlined in this proposal
will test the hypothesis that Sertoli cells influence the decision of
germ cells to enter meiosis. Cocultures of the somatic and germ cell
lines will be used to determine the impact of Sertoli cells on the
initiation of meiosis. Differential display of expressed mRNAs and
recombinant antibodies will be used to identify molecules involved in the
transition from mitosis to meiosis. Specific aim one will examine the
effects of Sertoli cells on the initiation of meiosis by the germ cells
and will identify molecules involved in the communication between the
Sertoli and germ cells which potentially regulate the entry of the germ
cells into meiosis. The second specific aim will identify molecules that
are expressed in germ cells as they leave the mitotic cell cycle and
enter the meiotic pathway. Finally, in specific aim three, recombinant
antibodies will be produced to germ cell surface proteins to obtain
reagents to early differentiation markers and identify additional
molecules which may be involved in the regulation of germ cell
differentiation. These experiments will provide insight into the
molecular mechanisms responsible for mammalian germ cell differentiation.
Eunice Kennedy Shriver National Institute of Child Health and Human Development
CFDA Code
DUNS Number
020520466
UEI
PHMKYKKJLQS1
Project Start Date
09-September-1995
Project End Date
Budget Start Date
01-April-1995
Budget End Date
31-March-1996
Project Funding Information for 1995
Total Funding
$23,700
Direct Costs
$23,700
Indirect Costs
Year
Funding IC
FY Total Cost by IC
1995
Eunice Kennedy Shriver National Institute of Child Health and Human Development
$23,700
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 1F32HD007964-01
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 1F32HD007964-01
Patents
No Patents information available for 1F32HD007964-01
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 1F32HD007964-01
Clinical Studies
No Clinical Studies information available for 1F32HD007964-01
News and More
Related News Releases
No news release information available for 1F32HD007964-01
History
No Historical information available for 1F32HD007964-01
Similar Projects
No Similar Projects information available for 1F32HD007964-01